{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:23Z","timestamp":1791859043279,"version":"4.3.4"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.seizure.2026.02.019","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:47:36Z","timestamp":1771919256000},"page":"24-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cannabidiol inhibits phenytoin clearance and can result in clinical changes: Two cases"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6411-7844","authenticated-orcid":false,"given":"Benjamin N","family":"Blond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Cardoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.seizure.2026.02.019_bib0001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/cont.0000000000001521","article-title":"Update on antiseizure medications 2025","volume":"31","author":"Abou-Khalil","year":"2025","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.seizure.2026.02.019_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1091978","article-title":"Pharmacovigilance on cannabidiol as an antiepileptic agent","volume":"14","author":"Ammendolia","year":"2023","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.seizure.2026.02.019_bib0003","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/epi.16674","article-title":"Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs","volume":"61","author":"Patsalos","year":"2020","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2026.02.019_bib0004","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/biom15121668","article-title":"Pharmacological and pharmacokinetic profile of cannabidiol in Human epilepsy: a review of metabolism, therapeutic drug monitoring, and interactions with antiseizure medications","volume":"15","author":"Na","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.seizure.2026.02.019_bib0005","series-title":"Epidiolex [Package insert]","year":"2023"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:43:40Z","timestamp":1775893420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":5,"alternative-id":["S1059131126000543"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.02.019","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol inhibits phenytoin clearance and can result in clinical changes: Two cases","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}